SCHEMBL14103801

SCHEMBL14103801

N#Cc1ccc(Oc2nc(-c3cccc(O)c3)nc3ccsc23)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 4/20 0.43
▸ MTOR P42345 2/20 0.43
▸ PIK3C2B O00750 1/20 0.43
▸ CCNE2 O96020 1/20 0.43
▸ PRKACA P17612 1/20 0.43
▸ PRKACG P22612 1/20 0.43
▸ PRKACB P22694 1/20 0.43
▸ CCNE1 P24864 1/20 0.43
▸ CDK2 P24941 1/20 0.43
▸ KDR P35968 1/20 0.43
▸ PIK3CB P42338 1/20 0.43
▸ PIK3CG P48736 1/20 0.43
▸ ABCG2 Q9UNQ0 3/20 0.37
▸ CYP11B1 P15538 2/20 0.37
▸ CYP11B2 P19099 2/20 0.37
▸ CYP1A2 P05177 4/20 0.35
▸ CYP3A4 P08684 4/20 0.35
▸ CYP2D6 P10635 3/20 0.35
▸ TSHR P16473 2/20 0.35
▸ ABCB1 P08183 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14104079 0.90 CYP1A2 (0.36) ABCG2CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL11990372 0.89 AR (0.39) ABCG2CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL14103888 0.89 PIK3CA (0.37) PIK3CAMTORABCG2CYP11B1CYP11B2
SCHEMBL4743431 0.89 MAPK1 (0.40) ABCG2CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL4738829 0.89 NR1I3 (0.40) ABCG2CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL4740912 0.89 ABCG2 (0.35) ABCG2CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL14103886 0.88 ABCG2 (0.44) ABCG2CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL14104180 0.87 PIK3CA (0.47) PIK3CAMTORPIK3C2BCCNE2PRKACA
SCHEMBL4740295 0.85 PTGS1 (0.40) PIK3CAKDRABCG2MEN1CYP2C19
SCHEMBL4573992 0.84 MAPK1 (0.44) CDK2ABCG2CYP2C19MAPK1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008092861-A1 BICYCLIC DERIVATIVES AS EP4 AGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-08-07 — — WO disclosed
Send feedback